125 related articles for article (PubMed ID: 25571293)
21. Simvastatin-nelfinavir interaction implicated in rhabdomyolysis and death.
Hare CB; Vu MP; Grunfeld C; Lampiris HW
Clin Infect Dis; 2002 Nov; 35(10):e111-2. PubMed ID: 12410494
[TBL] [Abstract][Full Text] [Related]
22. Development of a pharmacokinetic interaction model for co-administration of simvastatin and amlodipine.
Son H; Lee D; Lim LA; Jang SB; Roh H; Park K
Drug Metab Pharmacokinet; 2014; 29(2):120-8. PubMed ID: 23965645
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of drug interactions of GSK1292263 (a GPR119 agonist) with statins: from in vitro data to clinical study design.
Polli JW; Hussey E; Bush M; Generaux G; Smith G; Collins D; McMullen S; Turner N; Nunez DJ
Xenobiotica; 2013 Jun; 43(6):498-508. PubMed ID: 23256625
[TBL] [Abstract][Full Text] [Related]
24. Interaction between amlodipine and simvastatin in patients with hypercholesterolemia and hypertension.
Nishio S; Watanabe H; Kosuge K; Uchida S; Hayashi H; Ohashi K
Hypertens Res; 2005 Mar; 28(3):223-7. PubMed ID: 16097365
[TBL] [Abstract][Full Text] [Related]
25. Rhabdomyolysis secondary to a drug interaction between simvastatin and clarithromycin.
Lee AJ; Maddix DS
Ann Pharmacother; 2001 Jan; 35(1):26-31. PubMed ID: 11197581
[TBL] [Abstract][Full Text] [Related]
26. Effect of linagliptin (BI 1356) on the steady-state pharmacokinetics of simvastatin.
Graefe-Mody U; Huettner S; Stähle H; Ring A; Dugi KA
Int J Clin Pharmacol Ther; 2010 Jun; 48(6):367-74. PubMed ID: 20497745
[TBL] [Abstract][Full Text] [Related]
27. Simvastatin-fluconazole causing rhabdomyolysis.
Shaukat A; Benekli M; Vladutiu GD; Slack JL; Wetzler M; Baer MR
Ann Pharmacother; 2003; 37(7-8):1032-5. PubMed ID: 12841814
[TBL] [Abstract][Full Text] [Related]
28. Population pharmacokinetics and pharmacodynamics of nelfinavir and its active metabolite M8 in HIV-1-infected children.
Crommentuyn KM; Scherpbier HJ; Kuijpers TW; Mathôt RA; Huitema AD; Beijnen JH
Pediatr Infect Dis J; 2006 Jun; 25(6):538-43. PubMed ID: 16732153
[TBL] [Abstract][Full Text] [Related]
29. Effects of Silymarin on the In Vivo Pharmacokinetics of Simvastatin and Its Active Metabolite in Rats.
Li Y; Wu Y; Li YJ; Meng L; Ding CY; Dong ZJ
Molecules; 2019 Apr; 24(9):. PubMed ID: 31035343
[TBL] [Abstract][Full Text] [Related]
30. Study of the drug-drug interaction between simvastatin and cisapride in man.
Simard C; O'Hara GE; Prévost J; Guilbaud R; Masseé R; Turgeon J
Eur J Clin Pharmacol; 2001 Jun; 57(3):229-34. PubMed ID: 11497338
[TBL] [Abstract][Full Text] [Related]
31. Concomitant use of cytochrome P450 3A4 inhibitors and simvastatin.
Gruer PJ; Vega JM; Mercuri MF; Dobrinska MR; Tobert JA
Am J Cardiol; 1999 Oct; 84(7):811-5. PubMed ID: 10513779
[TBL] [Abstract][Full Text] [Related]
32. Rhabdomyolysis after concomitant use of cyclosporine, simvastatin, gemfibrozil, and itraconazole.
Maxa JL; Melton LB; Ogu CC; Sills MN; Limanni A
Ann Pharmacother; 2002 May; 36(5):820-3. PubMed ID: 11978159
[TBL] [Abstract][Full Text] [Related]
33. Duration of effect of grapefruit juice on the pharmacokinetics of the CYP3A4 substrate simvastatin.
Lilja JJ; Kivistö KT; Neuvonen PJ
Clin Pharmacol Ther; 2000 Oct; 68(4):384-90. PubMed ID: 11061578
[TBL] [Abstract][Full Text] [Related]
34. The interaction of diltiazem with simvastatin.
Mousa O; Brater DC; Sunblad KJ; Hall SD
Clin Pharmacol Ther; 2000 Mar; 67(3):267-74. PubMed ID: 10741630
[TBL] [Abstract][Full Text] [Related]
35. Development and Application of a Mechanistic Pharmacokinetic Model for Simvastatin and its Active Metabolite Simvastatin Acid Using an Integrated Population PBPK Approach.
Tsamandouras N; Dickinson G; Guo Y; Hall S; Rostami-Hodjegan A; Galetin A; Aarons L
Pharm Res; 2015 Jun; 32(6):1864-83. PubMed ID: 25446771
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetic interaction between nelfinavir and pravastatin in HIV-seronegative volunteers: ACTG Study A5108.
Aberg JA; Rosenkranz SL; Fichtenbaum CJ; Alston BL; Brobst SW; Segal Y; Gerber JG;
AIDS; 2006 Mar; 20(5):725-9. PubMed ID: 16514303
[TBL] [Abstract][Full Text] [Related]
37. A literature search on pharmacokinetic drug interactions of statins and analysis of how such interactions are reflected in package inserts in Japan.
Saito M; Hirata-Koizumi M; Urano T; Miyake S; Hasegawa R
J Clin Pharm Ther; 2005 Feb; 30(1):21-37. PubMed ID: 15659001
[TBL] [Abstract][Full Text] [Related]
38. Analysis of secondary care data to evaluate the clinical relevance of the drug-drug interaction between amlodipine and simvastatin.
Fuhrmann S; Koppen A; Seeling A; Knoth H; Schröder J
Z Evid Fortbild Qual Gesundhwes; 2019 Oct; 146():21-27. PubMed ID: 31324418
[TBL] [Abstract][Full Text] [Related]
39. Rhabdomyolysis in a Prostate Cancer Patient Taking Ketoconazole and Simvastatin: Case Report and Review of the Literature.
Watkins JL; Atkinson BJ; Pagliaro LC
Ann Pharmacother; 2011 Feb; 45(2):e9. PubMed ID: 21304039
[TBL] [Abstract][Full Text] [Related]
40. Baicalein inhibits the pharmacokinetics of simvastatin in rats
Meng M; Li X; Zhang X; Sun B
Pharm Biol; 2021 Dec; 59(1):880-883. PubMed ID: 34214011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]